The components of the insulin-like growth factor (IGF) axis have been investigated in the normal human thymus. Using ribonuclease protection assays (RPA), IGF-II transcripts were detected in the normal human thymus. By reverse transcriptase polymerase chain reaction (RT-PCR) analyses, promoters P3 and P4 were found to be active in the transcription of IGF2 gene within human thymic epithelial cells (TEC). No IGF-II mRNA could be detected in human lymphoid Jurkat T cells with 30 cycles of RT-PCR. By Northern blot analyses, IGFBP-2 to -6 (but not IGFBP-1) were found to be expressed in TEC with a predominance of IGFBP-4. Interestingly, Jurkat T cells only express IGFBP-2 but at high levels. The type 1 IGF receptor was detected in Jurkat T cells but not in human TEC. The identification of the components of the IGF axis within separate compartments of the human thymus adds further evidence for a role of this axis in the control of T-cell development. The precise influence of thymic IGF axis upon T-cell differentiation and immunological self-tolerance however needs to be further investigated.
The thymus is the primary lymphoid organ involved in the IGF-I was also detected in the thymus, but IGF-I distribution was restricted to macrophage-like thymic stromal cells (15) . development of competent and self-tolerant T lymphocytes (1) . The induction of thymic central T-cell self-tolerance is IGF-I mRNA and protein have also been identified in murine macrophage cell lines from thymic and non-thymic origin thought to be the consequence of T-cell apoptosis or the developmental arrest of immature T cells bearing a randomly (16) . IR proinsulin could not be identified by ICC in the human thymus. rearranged receptor for self-antigens presented in the thymic microenvironment (2-6). We showed in our previous studies IGF-II is a 67 amino acid peptide which is thought to be a growth regulator during foetal development (17, 18) . The that thymic epithelial and nurse cells (TEC/TNC ) from different species express neuroendocrine-related polypeptide human IGF2 gene is located on the chromosome 11p15 (19) . It contains nine exons and four promoters (20) , the activities precursors/genes belonging to neurohypophysial, tachykinin and neurotensin families (7-9). Thymic neuroendocrineof which are regulated in a tissue-and developmental-specific manner. Such specificity gives rise to multiple IGF-II tranrelated precursors have been proposed to recapitulate at the molecular level the dual role of the thymus in T-cell developscripts with different 5∞-and 3∞-non-coding regions (21) . The P1 promoter is only active in adult human liver and it yields ment and self-tolerance (10) (11) (12) . Regarding the insulin family, previous studies have reported a predominant expresa 5.3 Kb mRNA. P2, P3 and P4 promoters are active in foetal liver as well as in adult non-hepatic tissues where they sion of insulin-like growth factor-II (IGF-II ) over IGF-I in human foetal organs including the thymus (13, 14) . By activate the production of 5, 6 and 4.8 Kb transcripts, respectively (22) . immunocytochemistry (ICC ), we have reported that IGF-II is the dominant peptide of the insulin family synthesized by Currently, there is no information concerning the active promoter of IGF2 in thymic cells. In the first part of this TEC from human and rat thymus (15) . Immunoreactive (IR) or IGF-I RNA probes, respectively (33, 34). The riboprobes were synthesized study we analyse IGF2 gene expression in the thymus and from the 800-bp IGF-II-pSPT18 Sst II linearized plasmid, or 600-bp IGF-Iidentify the thymic active promoters by RNase protection pSPT18 Sma I using 5-10 units of the SP6 RNA polymerase from the Promega assay and RT-PCR respectively. transcription kit (Promega Corp.). The riboprobes are 440-and 660-nt in IGF activity is not only dependent on the regulation of length containing 20-nt of poly-linker sequence. Hybridization and RNase treatment were performed as described by Lambert et al. (33) , and the samples their synthesis but also on the presence of IGF receptors were submitted to electrophoresis on a 4% polyacrylamide sequencing gel on target cells: type 1 (IGF-1R) (23), type 2/mannosecontaining 8 M urea and dried gel were exposed to X-ray film for 48 h.
6-phosphate (IGF-2R) (24) IGF-receptors and insulin recep-
Reverse transcription polymerase chain reaction tors (25), as well as on the presence of IGF-binding proteins (IGFBPs) (26) . These IGFBPs are found in many body fluids IGF-II mRNA levels were analysed by RT-PCR. Five mg of total RNA were reverse-transcribed in the presence of 10 pmole of antisense primer: primer 9 and in the conditioned media of a wide variety of cell types ( (27) where they are presumed to regulate IGF bioavailability (Life Technologies), 1X first strand buffer, 10 mM dithiothreitol, 0.5 mM of and bioactivity for their receptors (28 Hercules, CA, USA). The 800-bp Pst I fragment of the human IGF-II cDNA probe (33) was labelled with [a-32P] dCTP (50 mCi at a specific activity of 3000 Ci/mmol; ICN ) by random priming using Ready To Go reaction mix
Materials and methods
(Pharmacia LKB). Unincorporated nucleotides were removed by gel filtration Human tissue samples on a Sephadex G50 column and the blotted membranes were hybridized for 16 h at 42°C to 5.107 c.p.m. of the probe. The washes were performed at Thymic fragments were obtained from children (aged from 6 months to 3 65°C as follows: twice in 40 mM Na 2 HPO 4 (pH 7.2), 5% SDS for 30 min years) undergoing corrective cardiovascular surgery for congenital cardiopathand twice in 40 mM Na 2 HPO 4 (pH 7.2), 1% SDS for 30 min. The blots were ies. Human liver and placenta samples were used as positive controls. Tissue exposed for 1 h to phosphorimager. samples were frozen in liquid nitrogen and stored at −70°C. This study was approved by the ethical committee of the University Hospital of Liège.
Northern blotting and hybridization TEC cultures
Total RNA were prepared from tissue samples and cell cultures as described above. Fifteen to 20 mg of TEC and Jurkat T cell line RNA and 5 mg of TEC cultures were obtained from thymic explants as described by liver or placenta RNA were loaded on a formaldehyde agarose gel following Martens et al. (33) . Briefly, surgical thymic fragments were cut and washed denaturationon. The gel was stained with ethidium bromide to visualize RNA twice by sedimentation for 5 min in HBSS ( ICN, Costa Mesa, CA, USA).
standards and ribosomal RNA (rRNA) and total RNA were blotted onto The small fragments (<2 mm) were cultured in Eagle's minimum essential Gene Screen Nylon membran (Dupont, NEN Research Product, Boston, medium containing D-valine (Life Technology, Gaithersburg, MD, USA) in USA). Hybridization were carried out at 42°C for 16 h according to the order to reduce fibroblast growth, supplemented with 2 mM -glutamine, manufacturer's instructions in 10 ml hybridization mixture containing 5.107 10 mM HEPES, 100 U/m; penicillin, 100 mg/ml streptomycin and 10% heatc.p.m. of 32P randomly primed probe (as described previously) and posthybridinactivated foetal calf serum (Life Technology). Fragments were allowed to ization washes were performed as follows: twice in 2×SSPE (20×SSPE: 3 M adhere to T-75 flasks in the same medium in a humidified atmosphere at NaCl, 0.02 M EDTA and 0.2 M NaH 2 PO 4 H 2 O) at room temperature for 37°C and 5% CO 2 . On day 17, explants and confluent cells were trypsinized 15 min, twice in 2×SSPE, 2% SDS at 65°C for 45 min, and finally twice in ( Trypsin Versene, BioWhittaker, Walkersville, MD, USA) and filtered through 0.1×SSPE at room temperature for 15 min. Hybridized membranes were nylon gaze to eliminate fragment residues. TEC were subcultured for 1 week exposed to X-Ray film. The blots were stripped and rehybridized (in the same before RNA extraction. Purity of human TEC cultures was around 75-85% condition) with a-32P-labelled b-actin probe (kindly provided by Dr Bell, GI ) as determined by Martens et al. (33) .
to assess RNA loading. Relative hybridization levels were determined by Jurkat T-cell line cultures densitometric analysis. In all cases, IGFBP levels were normalised with respect to the level of b-actin expression and to the length of the probes. The The human Jurkat T lymphoblast cell line (32) was cultured in RPMI 1640 following probes were used for hybridization: IGF-IR probe was obtained (BioWhittaker) containing 2 mM l-glutamine, 1% sodium pyruvate, 1% nonfrom ATCC ( Rockville, MD, USA), IGFBP-1 and-2 are from JCR essential amino acids, 100 U/ml penicillin, 100 mg/ml streptomycin and 10% Biopharmeuticals, Inc. (San Diego, CA, USA) and IGFBP-3, -4, -5 and-6 heat-inactivated FCS (Life Technology) in a humidified atmosphere at 37°C probes were purchased from Chiron Cell Corporation ( Emeryville, CA, USA). and 5% CO 2 .
RNA isolation

Results
Total RNA was extracted from tissue samples and cells using RNAzolTM B (Biotex Laboratories Inc. Houston, TX, USA) according to the manufacture instructions. The amount of total RNA was quantified by UV spectrophoto- The IGF-II message was already detected using 5 or 10 mg and in the lymphoid Jurkat T-cell line. Human liver RNA was used as a control tissue (Fig. 3) . IGFBP-3 (Fig. 3 ), of total placenta or thymic RNA, respectively, and its level increased with increasing amount of RNA. The size of the IGFBP-4 (Fig. 3) , IGFBP-5 (Fig. 3 ) and IGFBP-6 ( Fig. 3 ) transcripts were detected both in TEC and liver, but protected fragments were 20-nt shorter than the unhybridized probe (440-nt), due to the digestion of the linker sequences not in Jurkat T cells. By contrast, IGFBP-2 mRNA was abundant in the Jurkat T cells, and barely detectable in the transcribed from the pSPT18 vector. Two protected IGF-II fragments were detected. This result indicates that IGF2 is TEC (Fig. 3 ). IGFBP-1 mRNA was not detected neither in TEC, nor in Jurkat T cells (data not shown). The signals indeed expressed in the thymus, but does not provide information concerning the cellular origin of the transcripts nor the were quantified by densitometric analysis after rehybridization with b-actin probe. IGFBP mRNA levels were expressed identity of the active promoters. We could not detect any IGF-I mRNA in the human thymus using RPA (data not as the percentage of b-actin with respect to the probe length and compared to IGFBP expression in the liver. IGFBP-4 shown). These experiments were realized with three different thymuses and gave similar results.
IGF-II mRNA expression and identification of IGF2 active
mRNA was the dominant IGFBP in TEC and was 14-, 21-, and 20-fold more abundant than BP-3, BP-5, and BP-6 We also studied IGF-II mRNA expression in the Jurkat cells by RT-PCR. No amplification was observed after 30 respectively (in arbitrary units).
Using Northern blot analysis, type 1 IGF receptor cycles indicating that the expression level was probably below the detection level of this very sensitive technique (data (IGF-1R) mRNA (11 kb) was only found in Jurkat T cells (Fig. 3 ) . Human placenta was used as a positive control not shown).
To identify promoters responsibles of IGF-II mRNA tissue. These experiments were repeated and realized with different total RNA extracts. expression in cultured human TEC, RT-PCR analyses were performed using a common 3∞-primer derived from exon 9 and a 5∞-primer from exon 5 or 6, whose expression is under Discussion the control of promoters P3 and P4, respectively. The RT-PCR products specific for promoters P3 (662 bp, Fig. 2 ,
In the present study, we confirmed the expression of different members of the IGF axis (IGF-I, IGF-II, IGF-1R and lane 1) and P4 (596 bp, Fig. 2 , lane 2) were detected in TEC RNA. RT-PCR with primers from exon 9 and 7 IGFBPs) in the human thymus, in TEC primary cultures and in Jurkat, a human lymphoid T-cell line. Interestingly, our amplified a 450 bp PCR product which correspond to the common coding sequence for all IGF-II transcripts (Fig. 2 , results show that the thymic epithelial and lymphoid compartments exhibit different patterns of expression for members of lane 3). This experiment was realized three times and similar results were obtained. The identity of the amplified cDNAs the IGF axis: 1. TEC express IGF-II under the control of P3 and P4, most was controlled by Southern blot hybridization to a 800 bp human IGF-II cDNA probe containing exons 7, 8 and a of the IGFBPs (BP-2 to-6), but no IGF-1R mRNAs. 2. Jurkat T cells do not express IGF-II, express only IGFBP-2 portion of exon 9 (32) (Fig. 2) (44) have raised the possibility of a misinterpretation of this 14, 37). The difference between those results and our observations could be due to the difference in the developmental inhibitory effect. This IGFBP has also been detected in murine thymic macrophages and in macrophage cell lines stages of the analysed tissues. In transgenic mice overexpressing IGF-II, in-situ hybridization revealed the high expression (45) . As suggested by these authors, macrophage-derived IGFBP-4 might antagonize the extracellular effects of IGF-I. of the IGF-II transgene within non-lymphocyte cells of the thymic medulla (38, 39).
Similar experiments were performed with the lymphoid Jurkat T-cell line (32) . This cell line was used as a global Two IGF-II mRNA protected fragments were detected by RPA in the thymus. The shorter transcript may correspond representative of the lymphoid compartment in the thymus. By contrast with the subpopulations of thymic T cells (thymoto an IGF-II mRNA variant in the region detected by the probe used in the assay (40, 41) . cytes), the Jurkat T-cell line offers the advantage of an homogenous population which can be reproducibly analysed, The expression of the IGF-II gene in TEC is under the control of promoters P3 and P4 which are known to be active the disadvantage being that it is a cancer cell line so that all informations have to be interpreted with caution. No IGF-II in all foetal tissues, as well as in the extra-hepatic adult tissues (21) . To the best of our knowledge, the identity of mRNA could be detected in Jurkat T cells by RT-PCR analysis, while these cells were found to express both IGF-1R IGF-II gene promoters in TEC has not been addressed before.
IGF-I could not be detected in TEC by RPA. The absence mRNA, and IGFBP-2 trancripts. The presence of functional IGF-1R (46) and IGF-2R (47) on Jurkat cells has been of IGF-I transcripts is in accordance with our previous observations according which IR IGF-I was restricted to described before. These receptors have been reported to be expressed by freshly isolated immature and mature T lymphothymic macrophages (15) . In accordance with our own observations, Arkins et al. have shown that a variety of cytes (29, 30), as well as by human leukemic lymphoblasts (32) . murine macrophage cells and cell lines express the IGF-I mRNA, while this transcript was undetectable in the whole In summary this study confirms-at the molecular levelthe existence of IGF axis members in the human thymus with thymus (16).
Timsit and coworkers have reported that primary cultures a predominance of IGF-II synthesis within TEC and the expression of IGF receptors by lymphoid cells. The characterof TEC respond to IGF-I, an effect which could be blocked by an anti-IGF-I receptor antibody (42) . The apparent ization of a complete IGF system in a lymphopoietic site adds another argument for its implication in thymic T-cell discrepancy with the absence of IGF-1R mRNA in our study could be due to some differences in the conditions of TEC differentiation and self-tolerance (48) . IGF-II transgenic mice overexpress IGF-II mRNA in the thymus and spleen, and primary cultures, the presence of insulin receptor or in the regulation of expression of the IGF-1R gene.
their thymus shows a significant hyperplasia (35). In addition, the same group showed that overexpression of IGF-II TEC express different levels of IGFBP-2 to-6, with a predominance of IGFBP-4. IGFBP-4 is thought to be an increases thymic cellularity and stimulates the generation of phenotypically normal T cells with a preference to CD4+ inhibitor of IGF biological activity (43) . However, recent results concerning IGFBP-4 knock-out mice, presented by cells (38). The precise involvment of the IGF axis in T-cell 
